pH-responsive core-shell Fe₃O₄@MIL-100(Fe) nanocarriers coated with chitosan and alginate for oral delivery of 5-fluorouracil to colorectal cancer cells
Although 5-fluorouracil (5-FU) is extensively used in the clinical management of colorectal cancer, its therapeutic performance is hindered by dose-limiting systemic toxicity, rapid clearance, and a lack of site-specific delivery. In this study, a magnetic Fe 3 O 4 @MIL-100(Fe) core-shell nanocarrier was developed to systematically investigate how oppositely charged polysaccharide coatings, chitosan and alginate, regulate interfacial behavior and pH-responsive drug release. The nanocarrier was characterized by XRD, FTIR, SEM, and TEM, revealing a shell thickness of ~5.4 nm and a high surface area of 901.6 m 2 g −1 , which enabled a drug loading capacity of 42.67%. Successful coating was confirmed by zeta potential shifts from –12.72 mV (uncoated) to –37.84 mV (alginate) and + 22.4 mV (chitosan). In vitro drug release was pH-responsive. At pH 1.2, alginate coating markedly reduced early release (9.54% at 2 h), compared with 21.37% for chitosan and 36.26% for the uncoated carrier. At near-neutral pH, release increased, and the alginate-coated system released more 5-FU than the chitosan-coated system after 48 h (53.15% versus 46.49%; uncoated: 58.9%). MTT assays using HCT-116 cells showed time- and dose-dependent cytotoxicity. Among the nanoformulations, the chitosan-coated system exhibited the lowest IC 50 value (103.1 μg mL −1 at 48 h), indicating superior early-stage cytotoxic efficacy against HCT-116 cells. Live/dead fluorescence imaging qualitatively supported the cytotoxic effects of the formulations. These findings highlight coating behavior as a key design variable in oral MOF-based nanocarriers, offering preliminary insight into coating-dependent structure–function relationships to guide rational formulation design.